Webinar Recording: IP and Patenting for Engineers

Posted on November 25, 2020 — Jessica Jones Gupta

Hosted by the Penn Center for Innovation and Penn Engineering focused on the latest trends in intellectual property and patent protection with a focus on recent trends in the engineering and university commercialization sectors. The featured speaker was Aaron Rabinowitz, Partner at BakerHostetler.  

Webinar Recording: An Introduction to Venture Capital

Posted on — Jessica Jones Gupta

On November 12, 2020, the Penn Center for Innovation and Penn Medicine hosted Kirsten Leute of Osage University Partners for a VC 101 discussion on the basics any founder should know about venture capital.  

Philly start-ups pivot and scramble, trying to survive and thrive amid pandemic

Posted on November 23, 2020 — Jessica Jones Gupta

A look at the different ways businesses are changing to adapt to COVID. The article features Pennovation tenant Tozuda: “Many other entrepreneurs had to come up with new ideas. Jessie Garcia, founder of Tozuda (www.tozuda.com), a head impact sensor for concussions, survived a succession of hard knocks. Some studies involving team sports that Garcia was…

Uniting against an invisible foe

Posted on — Jessica Jones Gupta

All across the University, researchers have launched new areas of study, reaching across disciplinary boundaries to make stunning progress in combating COVID-19. Read More on Penn Today

‘This is just the beginning’: Cell and gene therapy pioneers June and Marrazzo on industry’s past, future

Posted on November 13, 2020 — Jessica Jones Gupta

The Philadelphia Business Journal hosted a “It’s in Our Genes” event that discussed cell and gene therapies and their development in Philadelphia.  The event featured Dr. Carl June, the director of the Center for Cellular Immunotherapies at Penn’s Perelman School of Medicine. The other is Jeff Marrazzo, the co-founder and CEO of Spark Therapeutics. The article…

Gene therapy pioneer develops a new approach to curb the side effects of treatment

Posted on — Jessica Jones Gupta

Gene therapies hold huge promise for inherited diseases that attack the nervous system — but studies show they can inadvertently damage sensitive nerve cells, triggering side effects like weakness, numbness, and intense pain. Penn scientist and gene therapy pioneer James Wilson has developed, a new tactic designed to make these treatments safer for the nervous…

This Philly Scientist’s Technology Helped Make the Pfizer COVID-19 Vaccine Possible

Posted on November 12, 2020 — Jessica Jones Gupta

Drew Weissman, a professor of infectious diseases at the University of Pennsylvania whose technology the promising vaccine is based on, explains how it works. Read More in Philadelphia Magazine

This Penn scientist paved the way for the Pfizer COVID-19 vaccine

Posted on — Jessica Jones Gupta

The work of Dr. Drew Weissman of the Perelman School of Medicine and his former Penn colleague Dr Katalin Karikó form the backbone of two vaccines for COVID-19, including the one for which dramatic early results were announced this week. Read More in the Philadelphia Inquirer

Neuraly announces Strategic Sponsored Research Agreement with Penn

Posted on November 11, 2020 — Jessica Jones Gupta

Neuraly, Inc, a clinical-stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, announced a strategic sponsored research agreement with the University of Pennsylvania to study the use of NLY01 to therapeutically target a neuroinflammatory mechanism of glaucoma. Read the Press Release

PCI’s Year in Review featured in the Penn Almanac

Posted on November 8, 2020 — Jessica Jones Gupta

Our Year in Review was featured in the Penn Almanac.  It shows PCI by the numbers including the almost $600M raised or received by Penn-affiliated startups in venture capital funding View the December 8th, 2020 Penn Almanac